Healthcare / Medical DistributionTokyo
$1548.00
-32.00 (-2.03%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-9.6B · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
68/100
B
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$74.9B
P/E
10.2x
↓EV/EBITDA
4.2x
↓ROE
6.9%
↑Gross Margin
8.2%
↓Debt/Equity
0.07
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+1.3%
FCF CAGR
—
FCF margin
-2.1%
FCF / Net income
-1.69x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $600.37B · net income $7.31B · FCF $-12.36B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $600.37B | $600.37B | $587.48B | $581.33B | $577.25B |
| Net Income | $7.31B | $7.31B | $5.84B | $4.83B | $4.77B |
| EBITDA | $14.56B | $14.56B | $12.16B | $11.56B | $10.87B |
| EPS | 149.02 | 149.02 | 115.03 | 92.69 | — |
| Gross Margin | 8.2% | 8.2% | 8.2% | 8.0% | 7.6% |
| Operating Margin | 1.0% | 1.0% | 0.9% | 0.7% | 0.5% |
| Net Margin | 1.2% | 1.2% | 1.0% | 0.8% | 0.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.07 | 0.07 | 0.09 | 0.10 | 0.12 |
| Current Ratio | 1.06 | 1.06 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-12.36B | $-12.36B | $18.47B | $-9.60B | $3.35B |
| Returns | |||||
| ROE | 6.9% | 6.9% | 5.6% | 4.9% | 4.8% |
| Valuation | |||||
| P/E | 10.16 | 10.16 | 10.43 | 9.71 | — |
| EV/EBITDA | 4.16 | 4.16 | 2.91 | 3.30 | 2.25 |
| P/B | 0.72 | 0.72 | 0.58 | 0.47 | 0.40 |
| Growth & Yield | |||||
| Revenue Growth | 2.2% | 2.2% | 1.1% | 0.7% | — |
| EPS Growth | 29.5% | 29.5% | 24.1% | — | — |
| Dividend Yield | 4.4% | 4.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-2.7%
EPS terminal req.
$137.36
Spread vs growth
32.2%
5Y implied EPS CAGR
2.2%
EPS terminal req.
$166.20
Spread vs growth
27.3%
10Y implied EPS CAGR
6.0%
EPS terminal req.
$267.67
Spread vs growth
23.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+29.5%
Start / end P/E
10.8x → 10.4x
EPS bridge
115.03 → 149.02
Residual
-1.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.